Sedative-, hypnotic-, or anxiolytic- (SHA-) related disorders include SHA intoxication, SHA withdrawal, and SHA-use disorder. These disorders result from abuse of a class of medications known as ...

Neurokinin NK1 receptor antagonists may have therapeutic potential in the treatment of anxiety and depression. Species variants in the NK1 receptor result in reduced affinity of NK1 receptor ...

Objective: The primary aim of this study was to evaluate the psychomotor effects of mexazolam versus placebo in patients with generalised anxiety disorder (GAD). Patients and methods: This was a ...

Disulfiram is a drug used to treat chronic alcoholism. However, studies suggest that it also inhibits chemokine receptor signaling pathways that are associated with the regulation of anxiety in ...

U.S. cancer survivors are significantly more likely to take medications for depression and anxiety compared with noncancer survivors, according to a study published online Aug. 19 in JAMA Network Open ...